MX2015016726A - Preparado farmaceutico. - Google Patents
Preparado farmaceutico.Info
- Publication number
- MX2015016726A MX2015016726A MX2015016726A MX2015016726A MX2015016726A MX 2015016726 A MX2015016726 A MX 2015016726A MX 2015016726 A MX2015016726 A MX 2015016726A MX 2015016726 A MX2015016726 A MX 2015016726A MX 2015016726 A MX2015016726 A MX 2015016726A
- Authority
- MX
- Mexico
- Prior art keywords
- solution
- alpha
- pharmaceutical preparation
- daughter
- selective binder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1075—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an enzyme
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1051—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Saccharide Compounds (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
Un método para generar una solución purificada de por lo menos un complejo de radionúclido emisor alfa. El método comprende poner en contacto una solución del complejo de radionúclido emisor alfa y por lo menos un núclido hijo que tiene por lo menos un ligante selectivo para los núclidos hijos y subsiguientemente separar la solución del ligante selectivo. También, un método para separar por lo menos un radionúclido hijo de una solución que comprende por lo menos un complejo de radionúclido emisor alfa. El método comprende poner en contacto la solución que tiene por lo menos un ligante selectivo para los núclidos hijos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1310028.4A GB201310028D0 (en) | 2013-06-05 | 2013-06-05 | Pharmaceutical preparation |
PCT/EP2014/061743 WO2014195423A1 (en) | 2013-06-05 | 2014-06-05 | Pharmaceutical preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015016726A true MX2015016726A (es) | 2016-06-28 |
MX366028B MX366028B (es) | 2019-06-21 |
Family
ID=48805787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015016726A MX366028B (es) | 2013-06-05 | 2014-06-05 | Un método para generar una solución purificada de por lo menos un isótopo de torio emisor alfa, un conjunto de elementos, un dispositivo de administración y un método para formar una solución inyectable. |
Country Status (36)
Country | Link |
---|---|
US (2) | US20160114063A1 (es) |
EP (1) | EP3003401B1 (es) |
JP (1) | JP6580559B2 (es) |
KR (1) | KR102321763B1 (es) |
CN (1) | CN105592863B (es) |
AP (1) | AP2015008894A0 (es) |
AU (1) | AU2014276885B2 (es) |
BR (1) | BR112015030298A2 (es) |
CA (1) | CA2914278C (es) |
CL (1) | CL2015003554A1 (es) |
CR (1) | CR20150642A (es) |
CU (1) | CU24535B1 (es) |
DK (1) | DK3003401T3 (es) |
DO (1) | DOP2015000294A (es) |
EA (1) | EA201501174A1 (es) |
ES (1) | ES2782624T3 (es) |
GB (1) | GB201310028D0 (es) |
HR (1) | HRP20200456T1 (es) |
IL (1) | IL242704B (es) |
LT (1) | LT3003401T (es) |
MA (1) | MA38650B1 (es) |
MX (1) | MX366028B (es) |
MY (1) | MY180717A (es) |
NI (1) | NI201500173A (es) |
PE (1) | PE20160215A1 (es) |
PH (1) | PH12015502715A1 (es) |
PL (1) | PL3003401T3 (es) |
PT (1) | PT3003401T (es) |
RS (1) | RS60091B1 (es) |
SA (1) | SA515370233B1 (es) |
SG (1) | SG11201509856RA (es) |
SI (1) | SI3003401T1 (es) |
TN (1) | TN2015000527A1 (es) |
UA (1) | UA120352C2 (es) |
WO (1) | WO2014195423A1 (es) |
ZA (1) | ZA201600027B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201600158D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Purification method |
GB201600161D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope purification method |
WO2022157094A2 (en) | 2021-01-22 | 2022-07-28 | Bayer Aktiengesellschaft | Lrrc15 antibodies and conjugates thereof |
NO347755B1 (en) * | 2021-10-21 | 2024-03-18 | Blue Wave Therapeutics Gmbh | Peptide-coupled alginate gels comprising radionuclides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5749042A (en) * | 1997-01-28 | 1998-05-05 | Battelle Memorial Institute | Bismuth generator method |
GB0308731D0 (en) * | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
WO2010126979A1 (en) * | 2009-04-29 | 2010-11-04 | Bio-Rad Laboratories, Inc. | Purification of immunoconjugates |
GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
GB201105298D0 (en) * | 2011-03-29 | 2011-05-11 | Algeta Asa | Pharmaceutical preparation |
-
2013
- 2013-06-05 GB GBGB1310028.4A patent/GB201310028D0/en not_active Ceased
-
2014
- 2014-06-05 CN CN201480044621.8A patent/CN105592863B/zh active Active
- 2014-06-05 PL PL14728571T patent/PL3003401T3/pl unknown
- 2014-06-05 LT LTEP14728571.2T patent/LT3003401T/lt unknown
- 2014-06-05 CA CA2914278A patent/CA2914278C/en active Active
- 2014-06-05 SI SI201431535T patent/SI3003401T1/sl unknown
- 2014-06-05 RS RS20200349A patent/RS60091B1/sr unknown
- 2014-06-05 JP JP2016517608A patent/JP6580559B2/ja not_active Expired - Fee Related
- 2014-06-05 UA UAA201512920A patent/UA120352C2/uk unknown
- 2014-06-05 TN TN2015000527A patent/TN2015000527A1/en unknown
- 2014-06-05 CU CU2015000174A patent/CU24535B1/es unknown
- 2014-06-05 MA MA38650A patent/MA38650B1/fr unknown
- 2014-06-05 US US14/896,424 patent/US20160114063A1/en not_active Abandoned
- 2014-06-05 DK DK14728571.2T patent/DK3003401T3/da active
- 2014-06-05 WO PCT/EP2014/061743 patent/WO2014195423A1/en active Application Filing
- 2014-06-05 EA EA201501174A patent/EA201501174A1/ru unknown
- 2014-06-05 ES ES14728571T patent/ES2782624T3/es active Active
- 2014-06-05 PE PE2015002566A patent/PE20160215A1/es unknown
- 2014-06-05 AU AU2014276885A patent/AU2014276885B2/en active Active
- 2014-06-05 AP AP2015008894A patent/AP2015008894A0/xx unknown
- 2014-06-05 PT PT147285712T patent/PT3003401T/pt unknown
- 2014-06-05 MY MYPI2015704399A patent/MY180717A/en unknown
- 2014-06-05 MX MX2015016726A patent/MX366028B/es active IP Right Grant
- 2014-06-05 EP EP14728571.2A patent/EP3003401B1/en active Active
- 2014-06-05 SG SG11201509856RA patent/SG11201509856RA/en unknown
- 2014-06-05 KR KR1020157036893A patent/KR102321763B1/ko active IP Right Grant
- 2014-06-05 BR BR112015030298A patent/BR112015030298A2/pt active Search and Examination
-
2015
- 2015-11-22 IL IL242704A patent/IL242704B/en active IP Right Grant
- 2015-12-03 SA SA515370233A patent/SA515370233B1/ar unknown
- 2015-12-04 DO DO2015000294A patent/DOP2015000294A/es unknown
- 2015-12-04 CL CL2015003554A patent/CL2015003554A1/es unknown
- 2015-12-04 CR CR20150642A patent/CR20150642A/es unknown
- 2015-12-04 NI NI201500173A patent/NI201500173A/es unknown
- 2015-12-04 PH PH12015502715A patent/PH12015502715A1/en unknown
-
2016
- 2016-01-04 ZA ZA2016/00027A patent/ZA201600027B/en unknown
-
2020
- 2020-03-19 HR HRP20200456TT patent/HRP20200456T1/hr unknown
-
2021
- 2021-05-04 US US17/307,857 patent/US20220023449A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1221060A1 (zh) | 用於產生音頻文件的系統和方法 | |
HK1249619A1 (zh) | 用於查詢數據源的系統和方法 | |
IL237525A (en) | Method for labeling a prostate-specific membrane antigen with a radioactive isotope | |
PH12018501199A1 (en) | Nicotine particle capsule | |
EP3160599A4 (en) | Mobile processing system for hazardous and radioactive isotope removal | |
PL3289591T3 (pl) | Układ do generowania radionuklidów i metoda wytwarzania radionuklidów | |
PH12015502715B1 (en) | Pharmaceutical preparation | |
PL3257052T3 (pl) | Układ do generowania radionuklidów | |
MX2016008369A (es) | Composicion farmaceutica que incluye palonosetron. | |
FI20135630A (fi) | Menetelmä kuparin ja jalometallien talteenottamiseksi | |
HK1201614A1 (en) | Synchronization method for distributed transaction and system thereof | |
GB2545390B (en) | Method and system for generating geophysical data | |
ZA201907263B (en) | High length isotopes separation column and method for assembly | |
PH12016500847A1 (en) | Multi-particulate drug delivery system | |
PL3049542T3 (pl) | Sposób selektywnego odzyskiwania ołowiu i srebra | |
EP3335236A4 (en) | RESEARCH OF TOLERANT LIBRARY TO ISOTOPES | |
PL3558418T3 (pl) | Układ do infuzji środków radiofarmaceutycznych o krótkim czasie życia | |
SI3046112T1 (sl) | Sistem za jemanje posod z jedrskim gorivom | |
GB201622269D0 (en) | The recovery method of high-performance parallel file storage system after malfunction | |
EP3391956A4 (en) | DEVICE AND METHOD FOR IMPAIR / PAIR SEPARATION AND IONIZATION OF PALLADIUM ISOTOPES | |
SG2013084512A (en) | Method and system for collecting and parsing market data from various sources | |
AU2015904596A0 (en) | Improved hydrometallurgical method for the removal of radionuclides from radioactive copper concentrates | |
GB201600413D0 (en) | System and method for generating long token and subtoken for processing an interaction | |
AU2015901818A0 (en) | Improved hydrometallurgical method for the removal of radionuclides from radioactive copper concentrates | |
GB201506284D0 (en) | Cyclist alarm system (proximity) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |